Még nem toboroz
Efficacy And Safety of Olatorepatide in Adults With Overweight or Obesity Without Diabetes
NCT07896265· 3. fázis· Regeneron Pharmaceuticals· Forrás
Még nem toboroz
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of CD388, a Novel Long-Acting Antiviral Conjugate, for the Prevention of Influenza in Adults and Adolescents at Higher Risk of Developing Influenza Complications
2026-527531-33-00· 3. fázis· Cidara Therapeutics Inc.· Forrás
Toboroz
Efficacy and Safety of Once-Daily Oral ASC30 Compared with Placebo in Participants with Obesity or Overweight with Type 2 Diabetes Mellitus
2026-526336-39-00· 3. fázis· Ascletis Pharma (China) Co. Ltd.· Forrás
Toboroz
Efficacy and Safety of Once-Daily Oral ASC30 Compared with Placebo in Participants with Obesity or Overweight with Weight-Related Comorbidities
2026-526172-23-00· 3. fázis· Ascletis Pharma (China) Co. Ltd.· Forrás
Toboroz
A study on the efficacy of a vaccine against influenza in adults ≥65 years of age
2026-526682-14-00· 3. fázis· GlaxoSmithKline Biologicals· Forrás
Toboroz
Dose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP
NCT07830719· 2. fázis· Novartis Pharmaceuticals· Forrás
Még nem toboroz
A Randomized, Double-Blind, Placebo-controlled, Parallel Arm, 52-week Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of Two Doses of EXPD-101 in Participants with COPD
2026-525216-34-00· 2. fázis· Expedition Therapeutics Inc.· Forrás
Toboroz
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
NCT07753993· 3. fázis· AstraZeneca· Forrás
Toboroz
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
NCT07784725· 3. fázis· AstraZeneca· Forrás
Fut, nem toboroz
A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)
NCT07400653· 3. fázis· Pfizer· Forrás
Toboroz
A study to investigate the efficacy, safety, tolerability and pharmacokinetics of PKN605 in participants with atrial fibrillation
2025-520518-79-00· 2. fázis· Novartis Pharma AG· Forrás
Fut, nem toboroz
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
NCT07311850· 3. fázis· Pfizer· Forrás
Toboroz
Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma
NCT07301736· 2. fázis· Chiesi Farmaceutici S.p.A.· Forrás
Fut, nem toboroz
Silexan® in mild to moderate major depressive disorder
2025-521744-37-00· 3. fázis· Dr. Willmar Schwabe GmbH & Co. KG· Forrás
Toboroz
A Study of Brenipatide in Participants With Alcohol Use Disorder
NCT07219953· 3. fázis· Eli Lilly and Company· Forrás
Toboroz
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
NCT07219966· 3. fázis· Eli Lilly and Company· Forrás
Toboroz
A study to investigate the effect of AZD6793 in participants with moderate to very severe chronic obstructive pulmonary disease
2025-520473-40-00· 2. fázis· AstraZeneca AB· Forrás
Toboroz
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT07064473· 3. fázis· Boehringer Ingelheim· Forrás
Fut, nem toboroz
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
NCT06981078· 2. fázis· Upstream Bio Inc.· Forrás
Toboroz
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
NCT06935370· 3. fázis· Boehringer Ingelheim· Forrás
Toboroz
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
NCT06883305· 3. fázis· AstraZeneca· Forrás
Toboroz
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
NCT06424288· 3. fázis· Boehringer Ingelheim· Forrás
Toboroz
Controlled clinical trial to investigate the efficacy and safety of MYRRHINIL-INTEST® versus placebo in patients with diarrhoea-dominant irritable bowel syndrome (IBS-D)
2024-514383-61-00· 4. fázis· REPHA GmbH Biologische Arzneimittel· Forrás
Fut, nem toboroz
Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)
NCT04199689· 3. fázis· Merck Sharp & Dohme LLC· Forrás